Zobrazeno 1 - 10
of 17
pro vyhledávání: '"Ana Gabriela Grajales"'
Autor:
Marianna Mitratza, Malak Elsobky, Caihua Liang, Robin Bruyndonckx, Aleksandra Polkowska-Kramek, Worku Biyadgie Ewnetu, Pimnara Peerawaranun, Thao Mai Phuong Tran, Charles Nuttens, Ana Gabriela Grajales, Sazini Nzula, Bradford D. Gessner, Elizabeth Begier
Publikováno v:
Infectious Diseases and Therapy, Vol 13, Iss 9, Pp 1949-1962 (2024)
Abstract Introduction Adult respiratory syncytial virus (RSV) burden is underestimated due to non-specific symptoms, limited standard-of-care and delayed testing, reduced diagnostic test sensitivity—particularly when using single diagnostic specime
Externí odkaz:
https://doaj.org/article/32df52896c5946d6b222db91296f3ba1
Autor:
Derek Lytle, Ana Gabriela Grajales Beltrán, Johnna Perdrizet, Nassim Ait Yahia, Alejandro Cane, Benjamin Yarnoff, Ruth Chapman
Publikováno v:
Human Vaccines & Immunotherapeutics, Vol 19, Iss 2 (2023)
This study assessed the cost-effectiveness of the 20-valent pneumococcal conjugate vaccine (PCV20) in Canadian infants aged
Externí odkaz:
https://doaj.org/article/0feaf406272f41d088edaf6ce870bc53
Autor:
Ana Gabriela Grajales Beltrán, Derek Lytle, Jelena Vojicic, Prerna Grover, Lidija Latifovic, Shane Golden, Juejing Ling, Brad Millson, Alejandro Cane
Publikováno v:
Vaccines, Vol 11, Iss 4, p 748 (2023)
The burden of all-cause community-acquired pneumonia (CAP), including pneumococcal pneumonia, is typically estimated using ICD codes where pneumonia is coded as the most responsible diagnosis (MRDx). Pneumonia may also be coded as other than most res
Externí odkaz:
https://doaj.org/article/48c5a2f95c8a47c2a5395ca57a142b4a
Autor:
Matthew Wasserman, Maria Gabriela Palacios, Ana Gabriela Grajales, F. Berenice Baez/Revueltas, Michele Wilson, Cheryl McDade, Raymond Farkouh
Publikováno v:
Human Vaccines & Immunotherapeutics, Vol 15, Iss 3, Pp 560-569 (2019)
Introduction: Pneumococcal diseases caused by Streptococcus pneumoniae represent a significant health and economic burden. Mexico has benefited from the inclusion of the 7-valent (PCV7) and 13-valent pneumococcal conjugate vaccines (PCV13) since thei
Externí odkaz:
https://doaj.org/article/bce77725061b4dd3b159e912c6f0891b
Autor:
Matt Wasserman, Maria Gabriela Palacios, Ana Gabriela Grajales, Michele Wilson, Cheryl McDade, Raymond Farkouh
Publikováno v:
Human Vaccines & Immunotherapeutics, Vol 15, Iss 3, Pp 572-574 (2019)
In a recent Letter, Gomez et. al. provided a critique of our original analysis estimating the clinical and economic impact of switching from the 13-valent (PCV13) to the 10-valent (PCV10) pneumococcal conjugate vaccine in Mexico. This comment address
Externí odkaz:
https://doaj.org/article/c772fdf8f00f4af3af77445a95ab1e52
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Publikováno v:
Vaccine.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::41910f904bbf6e8ac75df7fbdabac7c7
https://doi.org/10.1016/j.vaccine.2023.02.004
https://doi.org/10.1016/j.vaccine.2023.02.004
Autor:
Alejandro Cane, Jelena Vojicic, Bradford D Gessner, Jose A Suaya, Maria Major, Stephane B Dion, Rajeev M. Nepal, Ana Gabriela Grajales
Publikováno v:
Vaccine. 39:3007-3017
BACKGROUND In 2010-2011, the 13-valent pneumococcal conjugate vaccine (PCV13) replaced the 7- or 10-valent vaccine (PCV7 and PCV10, respectively) in pediatric immunization programs across Canada. For adults aged ≥65 years, the 23-valent pneumococca
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::38e975de0a05946b7642728675097f18
https://doi.org/10.1016/j.vaccine.2021.02.069
https://doi.org/10.1016/j.vaccine.2021.02.069
Autor:
F Berenice Baez, Matt Wasserman, Raymond Farkouh, Maria Gabriela Palacios, Ana Gabriela Grajales, Revueltas, Michele Wilson, Cheryl McDade
Publikováno v:
Human Vaccines & Immunotherapeutics
Introduction: Pneumococcal diseases caused by Streptococcus pneumoniae represent a significant health and economic burden. Mexico has benefited from the inclusion of the 7-valent (PCV7) and 13-valent pneumococcal conjugate vaccines (PCV13) since thei
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::96585f9f49691a2ed55c571597be7be4
http://europepmc.org/articles/PMC6605727
http://europepmc.org/articles/PMC6605727